Know Cancer

or
forgot password

Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers


N/A
N/A
N/A
Not Enrolling
Both
Lung Cancer

Thank you

Trial Information

Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers


Inclusion Criteria:



- Patients with histologically confirmed lung cancer who received standard
platinum-containing doublet chemotherapy followed by EGFR tyrosine kinase inhibitors.

Exclusion Criteria:

- non

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Principal Investigator

Hsin-Gjin Eugene Liu

Investigator Role:

Principal Investigator

Investigator Affiliation:

Taipei Medical University WanFang Hospital

Authority:

Taiwan: Department of Health

Study ID:

IRB98021

NCT ID:

NCT01141686

Start Date:

May 2009

Completion Date:

December 2009

Related Keywords:

  • Lung Cancer
  • lung cancer
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location